AzTrials
AzTrials

AphasiaPhase 2NCT07036406

Comparing Traditional Semantic Feature Analysis (tSFA) and Semantic Feature Analysis + Metacognitive Strategy Training (SFA+MST)

A Phase 2 study testing Semantic Feature Analysis (traditional) and Semantic Feature Analysis + Metacognitive Strategy Training in people with Aphasia and Aphasia Following Cerebral Infarction, run by Teachers College, Columbia University at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare the effectiveness of traditional Semantic Feature Analysis (SFA) treatment to a modified SFA protocol that includes Metacognitive Strategy Training (SFA+MST) for adults with acquired aphasia. Read more about this study

Who is it for?
Ages 18 to 89 years
What is being tested?
Semantic Feature Analysis (traditional) and Semantic Feature Analysis + Metacognitive Strategy Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteUnited States
Study dates
28 Jul 2025to Jul 2027
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 89 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have aphasia due to a single acute event (e.g., left-hemisphere stroke, traumatic brain injury)
  • Be at least six-months post aphasia-onset,
  • Be a proficient English speaker,
  • Have normal or corrected to normal hearing (i.e., hearing aids) and vision (i.e., eyeglasses),
  • Have no history of neurodegenerative disease (e.g., dementia), severe motor speech disorder, significant mental illness, psychiatric disorder, drug/alcohol abuse, or neurological condition that could influence their cognitive, language, and memory systems

Who cannot join

  • A history of neurodegenerative disease (e.g., dementia), severe motor speech disorder, significant mental illness, psychiatric disorder, drug/alcohol abuse, or neurological condition that could influence their cognitive, language, and memory systems,
  • Children under the age of 18,
  • Adults over the age of 89,
  • Uncorrected hearing and vision.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Victoria Tilton-Bolowsky, Ph.D. CCC-SLP contact

212-678-8302

veb2119@tc.columbia.edu

United States1 site, 1 recruiting
  • Teachers College, Columbia University

    New York, New York, 10027

    Victoria Tilton-Bolowsky, Ph.D. CCC-SLP, 212-678-8302, veb2119@tc.columbia.edu

    Recruiting

Other trials in United States

About this study

Official title: Comparing the Effectiveness of Traditional Semantic Feature Analysis (SFA) Versus SFA Plus Metacognitive Strategy Training (SFA+MST) for People With Acquired Aphasia

The goal of this clinical trial is to compare the effectiveness of traditional Semantic Feature Analysis (SFA) treatment to a modified SFA protocol that includes Metacognitive Strategy Training (SFA+MST) for adults with acquired aphasia. The main questions it aims to answer are:

  • What are the comparative outcomes in picture naming accuracy and strategy use during picture naming following 2 months of traditional SFA versus SFA + MST in adults with acquired aphasia?
  • What are the comparative outcomes in percent of informative content and rate of informative content during spontaneous speech production following 2 months of traditional SFA versus SFA + MST in adults with acquired aphasia?
Read more

Researchers will compare outcomes between these two treatments to see if SFA+MST yields larger effects in picture naming and spontaneous speech outcomes than traditional SFA.

Participants will complete:

  • 5-7 pre-treatment assessment sessions where they will be asked to name pictures, tell stories/describe pictures, answer questions, and complete questionnaires,
  • 3 treatment sessions of SFA *OR* SFA+MST per week for 8 weeks, for a total of 24 sessions,
  • 7 weekly probes (i.e., short, intermittent assessments throughout the treatment phase),
  • 3 post-treatment assessment sessions immediately after treatment ends, where they will complete the same assessment tasks as they did pre-treatment (e.g., naming pictures, telling stories, etc.),
  • 2 retention assessment sessions, one 30 days and the other 60 days following the final treatment session, where they will be asked to name pictures, tell stories/describe pictures, and describe what they learned during the study.
Being tested
Semantic Feature Analysis (traditional), Semantic Feature Analysis + Metacognitive Strategy Training
Keywords
Aphasia, Anomia, Stroke, Communication, Language
Medical subject headings
Aphasia, Anomia, Aphasia, Broca, Aphasia, Conduction, Stroke, Communication, Language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Semantic Feature Analysis (traditional)Behavioural

    This treatment involves naming pictures of objects, describing the objects' features (e.g., category membership, physical attributes, etc.), and creating sentences using the objects' names. It does not include direct metacognitive strategy training.

  • Semantic Feature Analysis + Metacognitive Strategy TrainingBehavioural

    This treatment involves metacognitive teaching and practice, naming pictures of objects, describing the objects' features (e.g., category membership, physical attributes, etc), creating sentences using the objects' names, debriefing on overall performance, and discussing recent and future opportunities for strategy implementation in real life.

Study groups in NCT07036406
Study groupRoleWhat they receive
Traditional Semantic Feature AnalysisActive comparatorA portion of the study participants will participate in traditional Semantic Feature Analysis treatment, as described in Gravier, M. L., Dickey, M. W., Hula, W. D., Evans, W. S., Owens, R. L., Winans-Mitrik, R. L., \& Doyle, P. J. (2018). What matters in semantic feature analysis: Practice-related predictors of treatment response in aphasia. American Journal of Speech-Language Pathology, 27(1S), 438-453. https://doi.org/10.1044/2017_AJSLP-16-0196. Briefly, this treatment involves naming pictures of objects, describing the objects' features (e.g., category membership, physical attributes, etc.), and creating sentences using the objects' names.
Receives: Behavioral: Semantic Feature Analysis (traditional)
Semantic Feature Analysis + Metacognitive Strategy TrainingExperimentalA portion of the study participants will participate in traditional Semantic Feature Analysis treatment, as described in Tilton-Bolowsky, V. E., Brock, L., Nunn, K., Evans, W. S., \& Vallila-Rohter, S. (2023). Incorporating metacognitive strategy training into semantic treatment promotes restitutive and substitutive gains in naming: A single-subject investigation. American journal of speech-language pathology, 32(5), 1979-2020. https://doi.org/10.1044/2023_AJSLP-22-00230. Briefly, this treatment involves metacognitive teaching and practice, naming pictures of objects, describing the objects' features (e.g., category membership, physical attributes, etc), creating sentences using the objects' names, debriefing on overall performance, and discussing recent and future opportunities for strategy implementation in real life.
Receives: Behavioral: Semantic Feature Analysis + Metacognitive Strategy Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Confrontation naming accuracy

    Participants will complete a 60-item confrontation naming assessment before, during, and after treatment. We will calculate the total number of items that participants name accurately across study phases.

    Measured: Change from Baseline through study completion, an average of 6 months

  2. Independent word-finding strategy use

    Using the 60-item confrontation naming assessment, we will evaluate instances in which participants independently use a specific word-finding strategy (describing or talking around the word) in instances where they cannot name items successfully, and calculate the proportions of incorrect responses with and without strategy use across study phases.

    Measured: Change from Baseline through study completion, an average of 6 months

Secondary outcomes (2)
  1. Discourse informativeness

    Participants will describe picture scenes and tell stories. We will calculate the amount of informative content in their descriptions/stories using Content Information Unit (%CIU; Nicholas \& Brookshire, 1993) analysis for descriptions/stories across study phases.

    Measured: Change from Baseline through study completion, an average of 6 months

  2. Discourse efficiency

    Participants will describe picture scenes and tell stories. We will calculate the rate of informative content in their descriptions/stories using Content Information Unit (CIU/minute; Nicholas \& Brookshire, 1993) analysis for descriptions/stories across study phases.

    Measured: Change from Baseline through study completion, an average of 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2025
  2. Study start28 Jul 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionJul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07036406
Sponsor's protocol ID
TeachersCCU
Status last verified
Jun 2026
First submitted
9 Jun 2025
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Nicholas LE, Brookshire RH. A system for quantifying the informativeness and efficiency of the connected speech of adults with aphasia. J Speech Hear Res. 1993 Apr;36(2):338-50. doi: 10.1044/jshr.3602.338.

    PubMed 8487525
  • Gravier ML, Dickey MW, Hula WD, Evans WS, Owens RL, Winans-Mitrik RL, Doyle PJ. What Matters in Semantic Feature Analysis: Practice-Related Predictors of Treatment Response in Aphasia. Am J Speech Lang Pathol. 2018 Mar 1;27(1S):438-453. doi: 10.1044/2017_AJSLP-16-0196.

    PubMed 29497754
  • Tilton-Bolowsky VE, Brock L, Nunn K, Evans WS, Vallila-Rohter S. Incorporating Metacognitive Strategy Training Into Semantic Treatment Promotes Restitutive and Substitutive Gains in Naming: A Single-Subject Investigation. Am J Speech Lang Pathol. 2023 Sep 11;32(5):1979-2020. doi: 10.1044/2023_AJSLP-22-00230. Epub 2023 Jul 11.

    PubMed 37433115

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Semantic Feature Analysis (traditional) and Semantic Feature Analysis + Metacognitive Strategy Training in people with Aphasia and Aphasia Following Cerebral Infarction, run by Teachers College, Columbia University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Victoria Tilton-Bolowsky, Ph.D. CCC-SLP (212-678-8302, veb2119@tc.columbia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Confrontation naming accuracy (time frame: Change from Baseline through study completion, an average of 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07036406, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in